EXPE
Expedia Group, Inc.
EXPE has the edge over TSLA overall, supported by stronger valuation and stronger fundamentals.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
EXPE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
EXPE's revenue, profitability, cash flow and balance sheet are all currently healthy.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
EXPE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $261 | — |
| Current | 15x | $261 | — |
| Cheap | 19x | $330 | +26% |
| Fair | 25x | $428 | +64% |
| Expensive | 41x | $701 | +169% |
Historical ranges are pointers, not guarantees.
EXPE has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
EXPE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
EXPE has the edge over TSLA on the outlook, with more favorable profitability expectations.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
EXPE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.30 | +42% |
| Q3 2026 | $17.09 | +65% |
| Q2 2026 | $16.00 | +99% |
| Q1 2026 | $11.32 | +35% |
| Q4 2025 | $9.81 | +9.6% |
| Q3 2025 | $10.35 | +34% |
| Q2 2025 | $8.06 | +46% |
| Q1 2025 | $8.38 | +59% |
| Q4 2024 | $8.95 | +69% |
EXPE has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
EXPE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.9B | +12% |
| Q2 2026 | $4.3B | +14% |
| Q1 2026 | $3.4B | +15% |
| Q4 2025 | $3.5B | +11% |
| Q3 2025 | $4.4B | +8.7% |
| Q2 2025 | $3.8B | +6.4% |
| Q1 2025 | $3B | +3.4% |
| Q4 2024 | $3.2B | +10% |
EXPE has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 27% | +3.4 points |
| Q2 2026 | 19% | +5.7 points |
| Q1 2026 | 7.3% | +9.7 points |
| Q4 2025 | 12% | +5.1 points |
| Q3 2025 | 23% | +4.7 points |
| Q2 2025 | 13% | +0.1 points |
| Q1 2025 | -2.3% | +1.5 points |
| Q4 2024 | 6.8% | +3.2 points |
EXPE has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
EXPE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4B | -$713M |
| Q2 2026 | $1.3B | +39% |
| Q1 2026 | $3.7B | +36% |
| Q4 2025 | $119M | +1600% |
| Q3 2025 | -$686M | +$1B |
| Q2 2025 | $921M | -30% |
| Q1 2025 | $2.8B | +2% |
| Q4 2024 | $7M | +$422M |
EXPE has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
EXPE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -272K shares |
| 1 year | -6.7% | -8.7M shares |
| 3 years | -17% | -25.5M shares |
| 5 years | -24% | -38.2M shares |
| Available history | -18% | -27.6M shares |
EXPE has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $669M |
| Q2 2026 | $270M |
| Q1 2026 | $788M |
| Q4 2025 | $327M |
| Q3 2025 | $531M |
| Q2 2025 | $688M |
| Q1 2025 | $384M |
| Q4 2024 | $198M |
EXPE spent $2.1B buying back its own shares over the past year, up 14% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
EXPE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | 1.0x | Very low |
EXPE's net debt is less than a year of its operating earnings (EBITDA).
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over EXPE on leverage, with a lower net debt burden relative to earnings.
EXPE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.3 | Neutral |
| Stochastic | 20.0 | Neutral |
EXPE's weekly RSI is 46 (neutral) and its Stochastic is 20 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
EXPE PE vs Consumer Cyclical Sector
| Metric | EXPE | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 15% below |
| PE % | 1 | 47 | 46 pts below |
EXPE has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
EXPE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $273.5 | 4.5% below |
| 20 week MA | $285.2 | 8.5% below |
| 50 week MA | $261.9 | 0.3% below |
| 100 week MA | $226.8 | 15% above |
| 200 week MA | $176.0 | 48% above |
EXPE has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 48% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over EXPE on trend strength, trading above more of its moving averages.
EXPE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.3 | $127.0 | +17% |
| 2021 | $127.0 | $183.8 | +45% |
| 2022 | $183.8 | $86.4 | -53% |
| 2023 | $86.4 | $151.8 | +76% |
| 2024 | $151.8 | $186.1 | +23% |
| 2025 | $186.1 | $287.6 | +55% |
| 2026 YTD | $287.6 | $261.1 | -9.2% |
EXPE has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.